Antibody Publications

  1. Borenstein-Katz A., Shulman A., Hamawi H., Leitner O. & Diskin R. (2019). Differential antibody-based immune response against isolated GP1 receptor-binding domains from Lassa and Junín viruses.  Journal of Virology. 2019 Apr , 93 (8).
  2. Gaborit N., Abdul-Hai A., Mancini M., Lindzen M., Lavi S., Leitner O., Mounier L., Chentouf M., Dunoyer S., Ghosh M., Larbouret C., Chardes T., Bazin H., Pelegrine A., Sela M. & Yarden Y. (2015). Examination of HER3 targeting in cancer using monoclonal antibodies.  Proceedings of the National Academy of Sciences of the United States of America. 2015 Jan , 112 (3):839-844.
  3. Lindzen M., Lavi S., Leitner O. & Yarden Y. (2010). Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands.  Proceedings of the National Academy of Sciences of the United States of America. 2010 Jul , 107 (28):12559-12563.
  4. Rubinstein D. B., Ziv R., Karmely M., Leitner O. & Wreschner D. (2006). Immunization with MUC1/X protein enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target cancer cells..  Journal of Clinical Oncology. 2006 Jun , 24 (18):558S-558S.
  5. Rubinstein D., Ziv R., Carmeli M., Leitner O. & Wreschner D. (2005). Immunization with MUC1/X protein enhances cDNA immunization in generating Anti-MUC1 alpha/beta junction antibodies that target cancer cells..  Clinical Cancer Research. 2005 Dec , 11 (24):8980S-8980S.
  6. Aharoni R., Teitelbaum D., Leitner O., Meshorer A., Sela M. & Arnon R. (2000). Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.  Proceedings of the National Academy of Sciences of the United States of America. 2000 Oct , 97 (21):11472-11477.
  7. Chen X., Levkowitz G., Tzahar E., Karunagaran D., Lavi S., BenBaruch N., Leitner O., Ratzkin B., Bacus S. & Yarden Y. (1996). An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB4.  Journal of Biological Chemistry. 1996 Mar , 271 (13):7620-7629.
  8. SHALITIN D., MAWASSI M., GAFNY R., Leitner O., CABILLY S., Eshhar Z. & BARJOSEPH M. (1994). SEROLOGICAL CHARACTERIZATION OF CITRUS TRISTEZA VIRUS ISOLATES FROM ISRAEL.  Annals of Applied Biology. 1994 Aug , 125 (1):105-113.
  9. BLECHMAN J., Lev S., BRIZZI M., Leitner O., PEGORARO L., Givol D. & Yarden Y. (1993). SOLUBLE C-KIT PROTEINS AND ANTIRECEPTOR MONOCLONAL-ANTIBODIES CONFINE THE BINDING-SITE OF THE STEM-CELL FACTOR.  Journal of Biological Chemistry. 1993 Feb , 268 (6):4399-4406.
  10. BERREBI A., Lev S., BASSOUS L., TRACHTENBROT L., Leitner O., Givol D. & Yarden Y. (1992). EXPRESSION OF THE STEM-CELL FACTOR (SCF) IN NORMAL AND VARIOUS HEMATOLOGICAL CONDITIONS USING A MONOCLONAL-ANTIBODY AGAINST THE HUMAN C-KIT SCF RECEPTOR.  Experimental Hematology. 1992 Jul , 20 (6):747-747.
  11. Novick D., ENGELMANN H., Revel M., Leitner O. & Rubinstein M. (1991). MONOCLONAL-ANTIBODIES TO THE SOLUBLE HUMAN IL-6 RECEPTOR - AFFINITY PURIFICATION, ELISA, AND INHIBITION OF LIGAND-BINDING.  Hybridoma. 1991 Feb , 10 (1):137-146.
  12. SHISHEVA A., Leitner O. & Shechter Y. (1991). A NOVEL-APPROACH FOR EVALUATING TYROSINE KINASE-ACTIVITY BASED ON THE RADIOIMMUNOLOGICAL DETERMINATION OF PHOSPHOTYROSINE.  Journal of Proteomics. 1991 Dec , 23 (4):307-314.
  13. STANCOVSKI I., HURWITZ E., Leitner O., ULLRICH A., Yarden Y. & SELA M. (1991). MECHANISTIC ASPECTS OF THE OPPOSING EFFECTS OF MONOCLONAL-ANTIBODIES TO THE ERBB2 RECEPTOR ON TUMOR-GROWTH.  Proceedings of the National Academy of Sciences of the United States of America. 1991 Oct , 88 (19):8691-8695.
  14. ENGELMANN H., HOLTMANN H., BRAKEBUSCH C., AVNI Y., SAROV I., NOPHAR Y., HADAS E., Leitner O. & Wallach D. (1990). ANTIBODIES TO A SOLUBLE FORM OF A TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR HAVE TNF-LIKE ACTIVITY.  Journal of Biological Chemistry. 1990 Aug , 265 (24):14497-14504.
  15. Novick D., ENGELMANN H., Wallach D., Leitner O., Revel M. & Rubinstein M. (1990). PURIFICATION OF SOLUBLE CYTOKINE RECEPTORS FROM NORMAL HUMAN URINE BY LIGAND-AFFINITY AND IMMUNOAFFINITY CHROMATOGRAPHY.  Journal of Chromatography. 1990 Jun , 510 :331-337.
  16. BRUDERMAN I., Cohen R., Leitner O., RONAH R., GUBER A., GRIFFEL B. & Geiger B. (1990). IMMUNOCYTOCHEMICAL CHARACTERIZATION OF LUNG-TUMORS IN FINE-NEEDLE ASPIRATION - THE USE OF CYTOKERATIN MONOCLONAL-ANTIBODIES FOR THE DIFFERENTIAL-DIAGNOSIS OF SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA.  Cancer. 1990 Oct , 66 (8):1817-1827.
  17. Novick D., ENGELMANN H., Leitner O., Wallach D., Revel M. & Rubinstein M. (1990). SOLUBLE CYTOKINE-RECEPTORS IN NORMAL HUMAN URINE - PURIFICATION, BIOLOGICAL-ACTIVITY AND MONOCLONAL-ANTIBODIES.  Lymphokine Research. 1990, 9 (4):580-580.
  18. LIFSCHITZMERCER B., CZERNOBILSKY B., Shezen E., DGANI R., Leitner O. & Geiger B. (1988). SELECTIVE EXPRESSION OF CYTOKERATIN POLYPEPTIDES IN VARIOUS EPITHELIA OF HUMAN BRENNER TUMOR.  Human Pathology. 1988 Jun , 19 (6):640-650.
  19. MARSHAK G. & Leitner O. (1987). CYTOKERATIN POLYPEPTIDES IN NORMAL AND METAPLASTIC HUMAN SALIVARY-GLAND EPITHELIA.  Journal Of Oral Pathology & Medicine. 1987 Oct , 16 (9):442-449.
  20. MARSHAK G., Leitner O. & Geiger B. (1987). CYTOKERATIN POLYPEPTIDE EXPRESSION DURING THE HISTOGENESIS OF GUINEA-PIG SUBMANDIBULAR SALIVARY-GLAND.  Development. 1987 Aug , 100 (4):699-711.